Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L29 pseudogene 18 (RPL29P18) is a processed pseudogene and not a protein-coding gene. Pseudogenes are segments of DNA that are similar to normal genes but typically non-functional; they do not produce functional proteins. RPL29P18 is related by sequence homology to the protein-coding gene Ribosomal protein L29 (RPL29), but it is not itself known to encode a functional product or serve as a therapeutic target[1][5]. There is no evidence that RPL29P18 participates in known biological functions or disease pathways, or that it has any established interaction with drugs or utility as a biomarker. Note: If you are interested in the functional ribosomal protein L29, refer to the canonical gene RPL29, which encodes a structural protein of the ribosome involved in protein synthesis[3][6][12]. RPL29 itself is the protein-coding gene with described biological roles, not the pseudogene RPL29P18.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L29 pseudogene 18 (RPL29P18).